Primary Cilia Are Frequently Present in Small Cell Lung Carcinomas but Not in Non-Small Cell Lung Carcinomas or Lung Carcinoids.


Journal

Laboratory investigation; a journal of technical methods and pathology
ISSN: 1530-0307
Titre abrégé: Lab Invest
Pays: United States
ID NLM: 0376617

Informations de publication

Date de publication:
02 2023
Historique:
received: 02 03 2022
revised: 30 06 2022
accepted: 11 08 2022
medline: 12 4 2023
entrez: 11 4 2023
pubmed: 12 4 2023
Statut: ppublish

Résumé

Most human malignant neoplasms show loss of primary cilia (PC). However, PC are known to be retained and involved in tumorigenesis in some types of neoplasms. The PC status in lung carcinomas remains largely uninvestigated. In this study, we comprehensively assessed the PC status in lung carcinomas. A total of 492 lung carcinomas, consisting of adenocarcinomas (ACs) (n = 319), squamous cell carcinomas (SCCs) (n = 152), and small cell lung carcinomas (SCLCs) (n = 21), were examined by immunohistochemical analysis using an antibody against ARL13B, a marker of PC. The PC-positive rate was markedly higher in SCLCs (81.0%) than in ACs (1.6%) and SCCs (7.9%). We subsequently performed analyses to characterize the PC-positive lung carcinomas further. PC-positive lung carcinomas were more numerous and had longer PC than normal cells. The presence of PC in these cells was not associated with the phase of the cell cycle. We also found that the PC were retained even in metastases from PC-positive lung carcinomas. Furthermore, the hedgehog signaling pathway was activated in PC-positive lung carcinomas. Because ARL13B immunohistochemistry of lung carcinoids (n = 10) also showed a statistically significantly lower rate (10.0%) of PC positivity than SCLCs, we searched for a gene(s) that might be upregulated in PC-positive SCLCs compared with lung carcinoids, but not in PC-negative carcinomas. This search, and further cell culture experiments, identified HYLS1 as a gene possessing the ability to regulate ciliogenesis in PC-positive lung carcinomas. In conclusion, our findings indicate that PC are frequently present in SCLCs but not in non-SCLCs (ACs and SCCs) or lung carcinoids, and their PC exhibit various specific pathobiological characteristics. This suggests an important link between lung carcinogenesis and PC.

Identifiants

pubmed: 37039149
pii: S0023-6837(22)00007-1
doi: 10.1016/j.labinv.2022.100007
pii:
doi:

Substances chimiques

Hedgehog Proteins 0
HYLS1 protein, human 0
Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100007

Informations de copyright

Copyright © 2022 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights reserved.

Auteurs

Kazuya Shinmura (K)

Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan. Electronic address: kzshinmu@hama-med.ac.jp.

Hisami Kato (H)

Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Hideya Kawasaki (H)

Institute for NanoSuit Research, Preeminent Medical Photonics Education and Research Center, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Takahiko Hariyama (T)

Institute for NanoSuit Research, Preeminent Medical Photonics Education and Research Center, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Kimio Yoshimura (K)

Department of Health Policy and Management, Keio University School of Medicine, Tokyo, Japan.

Kazuo Tsuchiya (K)

Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Hirofumi Watanabe (H)

Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Isao Ohta (I)

Advanced Research Facilities and Services, Preeminent Medical Photonics Education and Research Center, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Eri Asahina (E)

Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Fumiya Sumiyoshi (F)

Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Keisuke Hamada (K)

Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Yuichi Kawanishi (Y)

Advanced Research Facilities and Services, Preeminent Medical Photonics Education and Research Center, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Akikazu Kawase (A)

Department of Surgery 1, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Kazuhito Funai (K)

Department of Surgery 1, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Haruhiko Sugimura (H)

Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH